• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心室辅助装置(LVAD)速度递增时,舒张期肺动脉压与肺动脉楔压解耦与 LVAD 植入后预后不良相关。

Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation.

机构信息

Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.

Department of Surgery, University of Chicago Medical Center, Chicago, Illinois.

出版信息

J Card Fail. 2018 Sep;24(9):575-582. doi: 10.1016/j.cardfail.2018.08.003. Epub 2018 Aug 10.

DOI:10.1016/j.cardfail.2018.08.003
PMID:30103020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6221832/
Abstract

BACKGROUND

Decoupling between diastolic pulmonary arterial pressure (dPAP) and pulmonary arterial wedge pressure (PAWP) is an index of pulmonary vasculature remodeling and provides prognostic information. Furthermore, decoupling may change during incremental left ventricular assist device (LVAD) speed changes.

METHODS AND RESULTS

In this prospective study, patients underwent an echocardiographic and hemodynamic ramp test after LVAD implantation and were followed for 1 year. The change in decoupling (dPAP - PAWP) between the lowest and highest LVAD speeds during the ramp test was calculated. Survival and heart failure admission rates were assessed by means of Kaplan-Meier analysis. Eighty-seven patients were enrolled in the study: 54 had a Heartmate II LVAD (60.8 ± 9.3 years of age and 34 male) and 33 had an HVAD LVAD (58.6 ± 13.2 years of age and 20 male). Patients who experienced greater changes in decoupling (Δdecoupling >3 mm Hg) had a persistently elevated dPAP at incremental LVAD speed and had worse 1-year heart failure readmission-free survival compared with the group without significant changes in the degree of decoupling (41% vs 75%; P = .001).

CONCLUSIONS

An increase in decoupling between dPAP and PAWP at incremental LVAD speed changes was associated with worse prognosis in LVAD patients.

摘要

背景

舒张期肺动脉压(dPAP)与肺动脉楔压(PAWP)解耦是肺血管重构的指标,并提供预后信息。此外,解耦可能会在左心室辅助装置(LVAD)速度递增变化期间发生变化。

方法和结果

在这项前瞻性研究中,患者在 LVAD 植入后接受超声心动图和血流动力学斜坡试验,并随访 1 年。计算斜坡试验中最低和最高 LVAD 速度之间解耦(dPAP-PAWP)的变化。通过 Kaplan-Meier 分析评估生存率和心力衰竭入院率。研究共纳入 87 例患者:54 例使用 Heartmate II LVAD(60.8±9.3 岁,34 例男性),33 例使用 HVAD LVAD(58.6±13.2 岁,20 例男性)。与解耦程度无明显变化的组相比,解耦变化较大(Δdecoupling >3mmHg)的患者在递增 LVAD 速度时持续升高的 dPAP,1 年心力衰竭无再入院生存率较差(41%比 75%;P=0.001)。

结论

递增 LVAD 速度变化时 dPAP 与 PAWP 之间解耦的增加与 LVAD 患者的预后较差相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29c/6221832/320383494b27/nihms-985633-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29c/6221832/fbc5e2c941c3/nihms-985633-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29c/6221832/8e2eadd9514c/nihms-985633-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29c/6221832/320383494b27/nihms-985633-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29c/6221832/fbc5e2c941c3/nihms-985633-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29c/6221832/8e2eadd9514c/nihms-985633-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29c/6221832/320383494b27/nihms-985633-f0004.jpg

相似文献

1
Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation.左心室辅助装置(LVAD)速度递增时,舒张期肺动脉压与肺动脉楔压解耦与 LVAD 植入后预后不良相关。
J Card Fail. 2018 Sep;24(9):575-582. doi: 10.1016/j.cardfail.2018.08.003. Epub 2018 Aug 10.
2
Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.持续性血流心室辅助装置植入术后,舒张期肺动脉压与肺毛细血管楔压解耦作为预后因素
Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.117.003882.
3
Novel Left Heart Catheterization Ramp Protocol to Guide Hemodynamic Optimization in Patients Supported With Left Ventricular Assist Device Therapy.新型左心导管插入术斜坡方案指导左心室辅助装置治疗患者的血流动力学优化。
J Am Heart Assoc. 2019 Feb 19;8(4):e010232. doi: 10.1161/JAHA.118.010232.
4
Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices.舒张期肺动脉压与肺毛细血管楔压分离与左心室辅助装置患者右心室功能障碍和血液相容性相关不良事件相关。
J Am Heart Assoc. 2020 Apr 7;9(7):e014801. doi: 10.1161/JAHA.119.014801. Epub 2020 Mar 30.
5
3D Morphological Changes in LV and RV During LVAD Ramp Studies.左心室辅助装置升速研究中左、右心室的 3D 形态变化。
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):159-169. doi: 10.1016/j.jcmg.2016.12.019. Epub 2017 Apr 12.
6
Cannula and Pump Positions Are Associated With Left Ventricular Unloading and Clinical Outcome in Patients With HeartWare Left Ventricular Assist Device.在 HeartWare 左心室辅助装置治疗的患者中,导管和泵的位置与左心室卸载和临床结果相关。
J Card Fail. 2018 Mar;24(3):159-166. doi: 10.1016/j.cardfail.2017.09.013. Epub 2017 Oct 2.
7
A Useful Scoring System For Predicting Right Ventricular Assist Device Requirement Among Patients with a Paracorporeal Left Ventricular Assist Device.一种用于预测体外左心室辅助装置患者右心室辅助装置需求的有用评分系统。
Int Heart J. 2018 Sep 26;59(5):983-990. doi: 10.1536/ihj.17-487. Epub 2018 Aug 29.
8
Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates.左心室辅助装置支持期间的最佳血液动力学与降低再入院率相关。
Circ Heart Fail. 2019 Feb;12(2):e005094. doi: 10.1161/CIRCHEARTFAILURE.118.005094.
9
Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure Predicts Outcome in Heart Failure With Preserved Ejection Fraction.节段性室壁压力而非左心室舒张末期压力预测射血分数保留心力衰竭的预后。
JACC Heart Fail. 2017 Nov;5(11):795-801. doi: 10.1016/j.jchf.2017.08.005. Epub 2017 Oct 11.
10
Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.连续流左心室辅助装置治疗终末期心力衰竭患者血流动力学的正常化
Heart Lung Circ. 2014 Oct;23(10):963-9. doi: 10.1016/j.hlc.2014.04.259. Epub 2014 Jun 3.

引用本文的文献

1
The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure.沙库巴曲缬沙坦在心力衰竭相关肺动脉高压中的新作用。
Front Cardiovasc Med. 2023 May 18;10:1125014. doi: 10.3389/fcvm.2023.1125014. eCollection 2023.
2
Vascular Function in Continuous Flow LVADs: Implications for Clinical Practice.连续流左心室辅助装置中的血管功能:对临床实践的影响
Biomedicines. 2023 Mar 2;11(3):757. doi: 10.3390/biomedicines11030757.
3
Safety and feasibility of hemodynamic pulmonary artery pressure monitoring using the CardioMEMS device in LVAD management.

本文引用的文献

1
Repeated Ramp Tests on Stable LVAD Patients Reveal Patient-Specific Hemodynamic Fingerprint.稳定型 LVAD 患者的重复斜坡试验揭示了患者特异性血流动力学特征。
ASAIO J. 2018 Nov/Dec;64(6):701-707. doi: 10.1097/MAT.0000000000000705.
2
Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.持续性血流心室辅助装置植入术后,舒张期肺动脉压与肺毛细血管楔压解耦作为预后因素
Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.117.003882.
3
Hemodynamic Ramp Tests in Patients With Left Ventricular Assist Devices.
使用 CardioMEMS 装置监测血流动力学肺动脉压在 LVAD 管理中的安全性和可行性。
J Card Surg. 2021 Sep;36(9):3271-3280. doi: 10.1111/jocs.15767. Epub 2021 Jun 22.
4
Pulmonary vasodilator use in continuous-flow left ventricular assist device management.持续血流左心室辅助装置管理中肺血管扩张剂的使用
Ann Transl Med. 2021 Mar;9(6):522. doi: 10.21037/atm-20-4710.
5
Implication of Hemodynamic Assessment during Durable Left Ventricular Assist Device Support.持久左心室辅助装置支持期间血流动力学评估的意义。
Medicina (Kaunas). 2020 Aug 15;56(8):413. doi: 10.3390/medicina56080413.
6
Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices.舒张期肺动脉压与肺毛细血管楔压分离与左心室辅助装置患者右心室功能障碍和血液相容性相关不良事件相关。
J Am Heart Assoc. 2020 Apr 7;9(7):e014801. doi: 10.1161/JAHA.119.014801. Epub 2020 Mar 30.
7
Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation.左心室辅助装置植入后血液动力学的纵向轨迹。
J Card Fail. 2020 May;26(5):383-390. doi: 10.1016/j.cardfail.2020.01.020. Epub 2020 Feb 3.
8
Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices.托伐普坦治疗左心室辅助装置患者的短期疗效和安全性。
ASAIO J. 2020 Mar;66(3):253-257. doi: 10.1097/MAT.0000000000001079.
9
Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.舒张期肺动脉梯度作为左心室辅助装置植入后右心衰竭的预测因子。
J Am Heart Assoc. 2019 Aug 20;8(16):e012073. doi: 10.1161/JAHA.119.012073. Epub 2019 Aug 14.
10
Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV.晚期心力衰竭中的肺动脉高压:衰竭右心室和左心室的评估与管理
Curr Heart Fail Rep. 2019 Oct;16(5):119-129. doi: 10.1007/s11897-019-00431-4.
左心室辅助装置患者的血流动力学斜坡试验。
JACC Heart Fail. 2016 Mar;4(3):208-17. doi: 10.1016/j.jchf.2015.10.001. Epub 2015 Dec 30.
4
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015年欧洲心脏病学会(ESC)/欧洲呼吸学会(ERS)肺动脉高压诊断和治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断和治疗联合工作组:得到以下组织认可:欧洲儿科和先天性心脏病协会(AEPC)、国际心肺移植学会(ISHLT)。
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
5
Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.左心室辅助装置植入前肺血管阻力对移植后短期和长期生存的影响。
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1352-60, 1361.e1-2. doi: 10.1016/j.jtcvs.2015.07.012. Epub 2015 Jul 14.
6
Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.舒张期肺血管压力梯度:“不成比例”肺动脉高压预后的预测因子。
Chest. 2013 Mar;143(3):758-766. doi: 10.1378/chest.12-1653.
7
The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.2013年国际心肺移植学会机械循环支持指南:执行摘要
J Heart Lung Transplant. 2013 Feb;32(2):157-87. doi: 10.1016/j.healun.2012.09.013.
8
Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension.使用离心式左心室辅助装置作为严重心力衰竭伴继发性肺动脉高压患者候选资格的桥接治疗。
Eur J Cardiothorac Surg. 2013 Jun;43(6):1237-42. doi: 10.1093/ejcts/ezs678. Epub 2013 Jan 22.
9
Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study.新型超声心动图斜坡试验优化速度和诊断连续血流左心室辅助装置中装置血栓形成:哥伦比亚斜坡研究。
J Am Coll Cardiol. 2012 Oct 30;60(18):1764-75. doi: 10.1016/j.jacc.2012.07.052. Epub 2012 Oct 3.
10
How effective are continuous flow left ventricular assist devices in lowering high pulmonary artery pressures in heart transplant candidates?连续性左心室辅助装置在降低心脏移植候选者的肺动脉高压方面的效果如何?
Cardiol J. 2012;19(2):153-8. doi: 10.5603/cj.2012.0027.